DE1695114A1 - Verfahren zur Herstellung von neuen Furazanderivaten - Google Patents

Verfahren zur Herstellung von neuen Furazanderivaten

Info

Publication number
DE1695114A1
DE1695114A1 DE19681695114 DE1695114A DE1695114A1 DE 1695114 A1 DE1695114 A1 DE 1695114A1 DE 19681695114 DE19681695114 DE 19681695114 DE 1695114 A DE1695114 A DE 1695114A DE 1695114 A1 DE1695114 A1 DE 1695114A1
Authority
DE
Germany
Prior art keywords
general formula
compound
solution
furazan
meaning given
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681695114
Other languages
German (de)
English (en)
Inventor
Andre Dr Gagneux
Claude Dr Lehmann
Ernst Dr Renk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE1695114A1 publication Critical patent/DE1695114A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/081,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Networks Using Active Elements (AREA)
DE19681695114 1967-02-07 1968-02-06 Verfahren zur Herstellung von neuen Furazanderivaten Pending DE1695114A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH189467A CH479605A (de) 1967-02-07 1967-02-07 Verfahren zur Herstellung von neuen Furazanderivaten

Publications (1)

Publication Number Publication Date
DE1695114A1 true DE1695114A1 (de) 1972-03-30

Family

ID=4221079

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681695114 Pending DE1695114A1 (de) 1967-02-07 1968-02-06 Verfahren zur Herstellung von neuen Furazanderivaten

Country Status (14)

Country Link
US (1) US3594388A (en, 2012)
AT (2) AT277219B (en, 2012)
BE (1) BE710408A (en, 2012)
CH (3) CH479605A (en, 2012)
DE (1) DE1695114A1 (en, 2012)
DK (1) DK125285B (en, 2012)
ES (2) ES350186A1 (en, 2012)
FR (2) FR1574706A (en, 2012)
GB (1) GB1210602A (en, 2012)
IE (1) IE31939B1 (en, 2012)
IL (1) IL29423A (en, 2012)
NL (1) NL6801666A (en, 2012)
NO (1) NO121498B (en, 2012)
SE (1) SE345857B (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0132680B1 (de) * 1983-07-22 1987-01-28 Bayer Ag Substituierte Furazane
US4507485A (en) * 1984-01-23 1985-03-26 Bristol-Myers Company 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2 -receptor antagonist activity
WO2005012269A1 (ja) 2003-08-05 2005-02-10 Ajinomoto Co., Inc. 新規アゾール化合物
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1

Also Published As

Publication number Publication date
CH478825A (de) 1969-09-30
US3594388A (en) 1971-07-20
FR7425M (en, 2012) 1969-11-12
GB1210602A (en) 1970-10-28
CH479605A (de) 1969-10-15
AT279601B (de) 1970-03-10
IE31939B1 (en) 1973-02-21
CH481126A (de) 1969-11-15
NO121498B (en, 2012) 1971-03-08
NL6801666A (en, 2012) 1968-08-08
SE345857B (en, 2012) 1972-06-12
ES350185A1 (es) 1969-04-16
ES350186A1 (es) 1969-04-16
DK125285B (da) 1973-01-29
BE710408A (en, 2012) 1968-08-06
IL29423A (en) 1972-02-29
AT277219B (de) 1969-12-10
FR1574706A (en, 2012) 1969-07-18
IE31939L (en) 1968-08-07

Similar Documents

Publication Publication Date Title
EP0004279B1 (de) Verfahren zur Herstellung von 4-Pyridon-3-carbonsäuren, 1-Cyclopropyl-4-Pyridon-3-Carbonsäurederivate und diese enthaltende Arzneimittel
EP0004011A1 (de) Phenoxyalkylcarbonsäure-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) Die gastrointestinale Durchblutung fördernde Arzneimittel
WO1993004035A1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
EP0022078B1 (de) Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen
JPH082858B2 (ja) ビフェニルヒドロキサム酸類
DD238972A5 (de) Verfahren zur herstellung tricyclischer dihydropyridazinon-derivate
DE2015568B2 (de) S^-Dimethoxyindazol-S-carbonsäureamide
DE1695114A1 (de) Verfahren zur Herstellung von neuen Furazanderivaten
DE1618465C3 (de) Phenylessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1695115A1 (de) Verfahren zur Herstellung von neuen Furazanderivaten
CH502365A (de) Verfahren zur Herstellung von neuen Furazanderivaten
DE2605419A1 (de) 3-amino-4-carbamylpyrrolderivate und verfahren zu deren herstellung
DE2151487A1 (de) Pharmazeutische Massen
DE2521326A1 (de) Neue thienodiazepinderivate, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel
DE2031228A1 (de) Arylpyrazin und pynmidincar bonsauren
DE2001276A1 (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
AT280265B (de) Verfahren zur herstellung von neuen furazanderivaten
DE1795004A1 (de) Penicillansaeuren
DE1695220A1 (de) Verfahren zur Herstellung von Pyrolinverbindungen
DE2625163A1 (de) Alpha-chlorcarbonsaeuren und verfahren zu ihrer herstellung
DE2115763A1 (de) Neue Amine und Verfahren zu ihrer Herstellung
DE1136709B (de) Verfahren zur Herstellung von 2-Oxo-1, 2-dihydro-1, 4-benzodiazepinen
DE1795372C3 (de) 10.01.68 Japan 1501-68 Verfahren zur Herstellung von 5-(o-Halogenphenyl)-7-halogen-1,3-dihydro-2H-1,4-benzodiazepin-2-onen und 2-Aminomethylindole und ihre Salze
JPH03130252A (ja) 2―アミノ―5―メチルベンゾフェノン類及びその製造法